Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Change in Accured Expenses: 2020-2024

Historic Change in Accured Expenses for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to -$2.9 million.

  • Journey Medical's Change in Accured Expenses fell 3883.33% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year increase of 28944.44%. This contributed to the annual value of -$2.9 million for FY2024, which is 404.05% down from last year.
  • As of FY2024, Journey Medical's Change in Accured Expenses stood at -$2.9 million, which was down 404.05% from $962,000 recorded in FY2023.
  • Journey Medical's Change in Accured Expenses' 5-year high stood at $2.4 million during FY2020, with a 5-year trough of -$3.6 million in FY2022.
  • Over the past 3 years, Journey Medical's median Change in Accured Expenses value was -$2.9 million (recorded in 2024), while the average stood at -$1.8 million.
  • As far as peak fluctuations go, Journey Medical's Change in Accured Expenses spiked by 126.96% in 2023, and later crashed by 404.05% in 2024.
  • Yearly analysis of 5 years shows Journey Medical's Change in Accured Expenses stood at $2.4 million in 2020, then plummeted by 48.33% to $1.2 million in 2021, then plummeted by 388.91% to -$3.6 million in 2022, then soared by 126.96% to $962,000 in 2023, then tumbled by 404.05% to -$2.9 million in 2024.